Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1093 of 5804
-
Heat therapy gives new hope for advanced pancreatic cancer patients
Disease control Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) is a very aggressive cancer and may become the second leading cause of cancer death by 2030. About half of the patients are diagnosed late, when the cancer has already spread (mPDAC), and the outlook is very poor. Chemotherapy is currently …
Phase: NA • Sponsor: Roberto Valente • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Coil treatment may offer brain bleed patients a Surgery-Free option
Disease control Not yet recruitingThe study is a multi-center prospective, single-arm, post-market study evaluating the efficacy and radiologic and functional outcomes associated use of the Numen SILK coils for Middle Meningeal Artery (MMA) embolization following Chronic Subdural Hematoma (cSDH) compared to surgi…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a japanese ARDS drug fix deadly clots in septic shock?
Disease control Not yet recruitingSepsis-induced disseminated intravascular coagulation (DIC) is a severe complication occurring in one-third of patients with septic shock, for which no specific treatment currently exists. It results from excessive systemic activation of coagulation and impaired fibrinolysis, lea…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New group program aims to save LGBTQ+ veterans from suicide
Knowledge-focused Recruiting nowDespite the high risk of suicide among LGBTQ+ Veterans, there is currently no suicide-focused intervention for this population. This study will refine and pilot Qnnections, a novel group-based suicide prevention intervention that aims to increase social connection and functioning…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate if CALM-TF (Trauma-Focused Managing Cancer and Living Meaningfully) is effective in treating traumatic stress symptoms in women with advanced ovarian cancer. It will also learn whether the efficacy differs at new diagnosis versus …
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New hope for tough cancers: experimental drug TB511 enters human trials
Disease control Not yet recruiting1. Study population \[TB511 Monotherapy Cohort for Phase 1 and Phase 2a Clinical Trial\] Patients with advanced solid tumors who are either refractory or intolerant to standard of care (SoC). \[Immune checkpoint inhibitors (ICIs) Combination Therapy Cohort for Phase 2a Cl…
Phase: PHASE1, PHASE2 • Sponsor: Twinpig Biolab, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a tiny zap ease endometriosis agony? new trial aims to find out.
Symptom relief Not yet recruitingEndometriosis is a condition that often causes pelvic pain, particularly during menstruation but also continuously and over long periods. Pharmacological treatments are only moderately effective or are associated with adverse effects. In this context, the search for non-pharmacol…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Precision radiation boosts cancer fight in Late-Stage esophageal study
Disease control Not yet recruitingParticipants in this study will have esophageal cancer that has spread (metastasized) to other parts of the body either at initial diagnosis (synchronous) or after the cancer returned following treatment (recurrent). In Alberta, the current standard approach for treating esophag…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
HPV pill trial aims to clear precancerous cells without surgery
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of Papillex® on the regression of abnormal cervical cells caused by HPV in women with a cervical intraepithelial neoplasia (CIN) 1 or 2 diagnosis. The main question it aims to answer is: Is there a differe…
Phase: NA • Sponsor: Papillex Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Hypnosis may replace pills for Needle-Phobic kids
Symptom relief Not yet recruitingThe proposed study aims to evaluate the effectiveness of hypnotherapy as a non-pharmacological intervention for managing pain and anxiety during needle-related medical procedures in children aged 5 to 17 years. This research addresses a significant gap in pediatric healthcare, wh…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New Non-Opioid drug could cut painkiller use after knee surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a non-opioid pain medicine called suzetrigine works to treat pain after total knee replacement surgery in adults. It will also learn about the safety of suzetrigine. The main questions it aims to answer are: Does suzetrigine lower t…
Phase: PHASE3 • Sponsor: AdventHealth • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to fix heart risk calculators that fail women
Knowledge-focused Not yet recruitingThis retrospective observational study, part of the EU-funded CARAMEL project, aims to develop and validate personalized cardiovascular disease (CVD) risk assessment models specifically designed for menopausal and perimenopausal women (ages 40-60). The study leverages Real World …
Sponsor: Hospital Universitario Virgen Macarena • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Can acupuncture help you quit antidepressants?
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the clinical efficacy of intradermal acupuncture as an adjunctive intervention to assist selective serotonin reuptake inhibitor (SSRI) dose reduction or discontinuation in adult patients with major depressive disorder (MDD). Parti…
Phase: NA • Sponsor: First People's Hospital of Hangzhou • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New radiation applicator aims to treat rectal cancer without surgery
Disease control Not yet recruitingRectal cancer is a common type of cancer and an important cause of illness and death worldwide. In 2020, cancers of the colon and rectum were the fourth most common cancers globally, and about one third of these cases were rectal cancer. Surgery is the main treatment for rectal c…
Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?
Disease control Not yet recruitingThe objective of this randomized control clinical trial is to learn the role of albumin in patients with acute variceal bleed. The trial will include all adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, …
Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a Two-Drug combo tame Crohn's in kids?
Disease control Not yet recruitingThe goal of this clinical trial is to investigate whether there are significant differences in the efficacy of infliximab monotherapy and combined azathioprine therapy in treating pediatric Crohn's disease, as well as whether there are differences in the safety of these two treat…
Phase: NA • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
More chemo before surgery: better odds for rare thymic cancer?
Disease control Not yet recruitingThis randomized controlled trial compares 6 versus 3 cycles of neoadjuvant chemotherapy in patients with potentially resectable locally advanced thymic epithelial tumors (TETs, WHO type AB/B/C, AJCC TNM stage IIIA-IVA). Patients are randomized 1:1 to receive either 6 or 3 cycles …
Phase: PHASE2, PHASE3 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Virus vs chemo: new hope for stomach cancer patients?
Disease control Not yet recruitingThis study is a prospective, multicenter, open-label, randomized controlled clinical trial, planned to enroll 30 patients with advanced gastric cancer and peritoneal metastasis. It aims to evaluate the safety and efficacy of systemic therapy plus Pressurized Intra-Peritoneal Aero…
Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Can pressurized oxygen calm the storm of PTSD?
Symptom relief Recruiting nowPost-traumatic stress disorder (PTSD), affecting approximately 6% of the general population and up to one-third of individuals exposed to combat zones and disasters, is a significant contributor to morbidity and mortality among IDF personnel. Hyperbaric oxygen therapy (HBOT), in …
Phase: NA • Sponsor: Medical Corps, Israel Defense Force • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New hope for painful hand and foot skin disease: experimental drug enters trial
Disease control Recruiting nowPalmoplantar pustulosis (PPP) is a chronic and recurrent skin disease, mainly characterized by erythema, pustules and scales on the palms and soles, often accompanied by itching and pain, which seriously affects the quality of life of patients. Currently, the treatment options fo…
Phase: PHASE4 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC